Do HIV-positive adult immigrants need to be screened for measles–mumps–rubella and varicella zoster virus immunization?

References

• Advisory Committee on Immunization. (2012). Recommended adult immunization schedule: United States, 2012. Annals of Internal Medicine, 156(3), 211–217. doi:10.1059/0003-4819-156-3-201202070-00388
   PubMed Web of Science ®Google Scholar
• Aurpibul, L., Puthanakit, T., Sirisanthana, T., & Sirisanthana, V. (2007). Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy. Clinical Infectious Diseases, 45(5), 637–642. doi:10.1086/520651
   PubMed Web of Science ®Google Scholar
• Aurpibul, L., Puthanakit, T., Sirisanthana, T., & Sirisanthana, V. (2010). Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy. Clinical Infectious Diseases, 50(10), 1415–1418. doi:10.1086/652150
   PubMed Web of Science ®Google Scholar
• Bekker, V., Scherpbier, H., Pajkrt, D., Jurriaans, S., Zaaijer, H., & Kuijpers, T. W. (2006). Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: Loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics, 118(2), e315–322. doi:10.1542/peds.2005-2616
   PubMed Web of Science ®Google Scholar
• Belaunzaran-Zamudio, P. F., Garcia-Leon, M. L., Wong-Chew, R. M., Villasis-Keever, A., Cuellar-Rodriguez, J., Mosqueda-Gomez, J. L., … Sierra-Madero, J. G. (2009). Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART. Vaccine, 27(50), 7059–7064. doi:10.1016/j.vaccine.2009.09.063
   PubMed Web of Science ®Google Scholar
• Berkelhamer, S., Borock, E., Elsen, C., Englund, J., & Johnson, D. (2001). Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children. Clinical Infectious Diseases, 32(7), 1090–1094. doi:10.1086/319591
   PubMed Web of Science ®Google Scholar
• Cagigi, A., Nilsson, A., Pensieroso, S., & Chiodi, F. (2010). Dysfunctional B-cell responses during HIV-1 infection: Implication for influenza vaccination and highly active antiretroviral therapy. Lancet Infectious Diseases, 10(7), 499–503. doi:10.1016/s1473-3099(10)70117-1
   PubMed Web of Science ®Google Scholar
• Comunidad de Madrid. (2010). Calendario de vacunación para adultos [Adults vaccination schedule]. Madrid: Servicio Madrileño de Salud. Dirección General de Atención Primaria.
   Google Scholar
• Diez, M., Oliva, J., Sanchez, F., Vives, N., Cevallos, C., Izquierdo, A., & Grupo SINIVIH. (2012). Incidence of new HIV diagnoses in Spain, 2004–2009. Gaceta Sanitaria, 26(2), 107–115. doi:10.1016/j.gaceta.2011.07.023
   PubMed Web of Science ®Google Scholar
• Geretti, A., Brook, G., Cameron, C., Chadwick, D., Heyderman, R., MacMahon, E., … Schuhwerk, M. (2008). British HIV Association guidelines for immunization of HIV-infected adults 2008. HIV Medicine, 9(10), 795–848. doi: 10.1111/j.1468-1293.2008.00637.x
   PubMed Web of Science ®Google Scholar
• GK, S. (2011). Use of MMR vaccine among persons with HIV infection. Retrieved from http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-oct11/04-MMR-Siberry.pdf
   Google Scholar
• Greenaway, C., Dongier, P., Boivin, J. F., Tapiero, B., Miller, M., & Schwartzman, K. (2007). Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees. Annals of Internal Medicine, 146(1), 20–24.
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadística. (2010). Población por lugar de nacimiento y sexo. Avance del padrón municipal a 1 de enero de 2010 [Population by place of birth and sex. Advance of the municipal registry at January 1st 2010]. Madrid.
   Google Scholar
• Kaplan, J. E., Benson, C., Holmes, K. H., Brooks, J. T., Pau, A., Masur, H., … HIV Medicine Association of the Infectious Diseases Society of America. (2009). Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recommendations and Reports, 58(RR-4), 1–207; quiz CE201–204. doi:rr5804a1 [pii]
   Google Scholar
• Kemper, C. A., Zolopa, A. R., Hamilton, J. R., Fenstersheib, M., Bhatia, G., & Deresinski, S. C. (1992). Prevalence of measles antibodies in adults with HIV infection: Possible risk factors of measles seronegativity. AIDS, 6(11), 1321–1325. doi: 10.1097/00002030-199211000-00013
   PubMed Web of Science ®Google Scholar
• Lange, C. G., Lederman, M. M., Medvik, K., Asaad, R., Wild, M., Kalayjian, R., & Valdez, H. (2003). Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection. AIDS, 17(14), 2015–2023. doi:10.1097/01.aids.0000076312.76477.b5
   PubMed Web of Science ®Google Scholar
• Levin, M. J., Gershon, A. A., Weinberg, A., Song, L. Y., Fentin, T., Nowak, B., & Pediatric AIDS Clinical Trials Group 265 Team. (2006). Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. Journal of Infectious Diseases, 194(2), 247–255. doi:10.1086/505149
   PubMed Web of Science ®Google Scholar
• Llenas-Garcia, J., Rubio, R., Hernando, A., Fiorante, S., Maseda, D., Matarranz, M., … Pulido, F. (2012). Clinico-epidemiological characteristics of HIV-positive immigrants: Study of 371 cases. Enfermedades Infecciosas y Microbiología Clínica, 30(8), 441–451. doi:10.1016/j.eimc.2012.01.009
   PubMed Web of Science ®Google Scholar
• Molton, J., Smith, C., Chaytor, S., Maple, P., Brown, K., Johnson, M., & Geretti, A. M. (2010). Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults. Journal of Infection, 61(1), 73–80. doi:10.1016/j.jinf.2010.04.004
   PubMed Web of Science ®Google Scholar
• Perez-Farinos, N., Garcia-Comas, L., Ramirez-Fernandez, R., Sanz, J. C., Barranco, D., Garcia-Fernandez, C., & Ordobas, M. (2008). Seroprevalence of antibodies to varicella-zoster virus in Madrid (Spain) in the absence of vaccination. Central European Journal of Public Health, 16(1), 41–44.
   PubMedGoogle Scholar
• Quinn, K. J., McCarty, E. J., Quah, S. P., Emerson, C. R., & Donnelly, C. M. (2012). Managing vaccines: Defining the remit of primary care and specialist HIV clinics in the delivery of immunization to individuals with HIV infection. International Journal of STD & AIDS, 23(2), 136–137. doi:10.1258/ijsa.2011.011231
   PubMed Web of Science ®Google Scholar
• Sanz Moreno, J. C., Garcia Comas, L., Ramirez Fernandez, R., Ramos Blazquez, B., & Ordobas Gavin, M. (2009). Evolucion del sarampion, rubeola y parotiditis desde la III Encuesta de serovigilancia de la Comunidad de Madrid 1999–2000 (III ESVCM). Revista Española de Salud Publica, 83(5), 625–637.
   PubMedGoogle Scholar
• Son, M., Shapiro, E. D., LaRussa, P., Neu, N., Michalik, D. E., Meglin, M., … Gershon, A. A. (2010). Effectiveness of varicella vaccine in children infected with HIV. Journal of Infectious Diseases, 201(12), 1806–1810. doi:10.1086/652798
   PubMed Web of Science ®Google Scholar
• Sprauer, M. A., Markowitz, L. E., Nicholson, J. K., Holman, R. C., Deforest, A., Dales, L. G., & Khoury, N. K. (1993). Response of human immunodeficiency virus-infected adults to measles-rubella vaccination. Journal of Acquired Immune Deficiency Syndromes, 6(9), 1013–1016.
   PubMed Web of Science ®Google Scholar
• Stermole, B. M., Grandits, G. A., Roediger, M. P., Clark, B. M., Ganesan, A., Weintrob, A. C., … Landrum, M. L. (2011). Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults. Vaccine, 29(16), 2874–2880. doi:10.1016/j.vaccine.2011.02.013
   PubMed Web of Science ®Google Scholar
• Taweesith, W., Puthanakit, T., Kowitdamrong, E., Bunupuradah, T., Wongngam, W., Phasomsap, C., … Pancharoen, C. (2011). The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children. Pediatric Infectious Disease Journal, 30(4), 320–324. doi:10.1097/INF.0b013e3181fe0868
   PubMed Web of Science ®Google Scholar
• Thierfelder, C., Weber, R., Elzi, L., Furrer, H., Cavassini, M., Calmy, A., … Swiss HIV Cohort Study Group. (2012). Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study(*). HIV Medicine, 13(2), 118–126. doi:10.1111/j.1468-1293.2011.00949.x
   PubMed Web of Science ®Google Scholar
• Vacunas recomendadas en adulto. (2004). Grupo de trabajo de vacunación de adultos de la ponencia de programas y registro de vacunaciones. Vacunación en adultos. Recomendaciones 2004 [Adults vaccination. 2004 Recommendations] (pp. 9–56). Madrid: Ministerio de Sanidad y Consumo.
   Google Scholar
• Valerio, L., Escriba, J. M., Fernandez-Vazquez, J., Roca, C., Milozzi, J., Solsona, L., & Molina, I. (2009). Biogeographical origin and varicella risk in the adult immigration population in Catalonia, Spain (2004–2006). Euro Surveillance, 14(37), 19332.
   PubMedGoogle Scholar
• Vargas-Leguas, H., Campins Marti, M., Juste Sanchez, C., Martinez Gomez, X., Hermosilla Perez, E., & Cabero Roura, L. (2009). Susceptibilidad a la rubeola en gestantes inmigrantes con residencia en Cataluna. Medicina Clinica, 132(9), 344–347. doi:10.1016/j.medcli.2008.05.018
   PubMed Web of Science ®Google Scholar
• Wallace, M. R., Hooper, D. G., Graves, S. J., & Malone, J. L. (1994). Measles seroprevalence and vaccine response in HIV-infected adults. Vaccine, 12(13), 1222–1224. doi: 10.1016/0264-410X(94)90247-X
   PubMed Web of Science ®Google Scholar
• Weinberg, A., Levin, M. J., & Macgregor, R. R. (2010). Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults. Human Vaccines, 6(4), 318–321. doi: 10.4161/hv.6.4.10654
   PubMed Web of Science ®Google Scholar
• Wood, S. M., Shah, S. S., Steenhoff, A. P., & Rutstein, R. M. (2008). Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006. Pediatrics, 121(1), e150–156. doi:10.1542/peds.2007-0564
   PubMed Web of Science ®Google Scholar